The role of endothelins and their receptors in heart failure

被引:99
作者
Giannessi, D [1 ]
Del Ry, S [1 ]
Vitale, RL [1 ]
机构
[1] CNR, Inst Clin Physiol, Lab Cardiovasc Biochem, I-56100 Pisa, Italy
关键词
endothelin; receptors; heart failure; endothelin antagonists; anti-endothelin therapy;
D O I
10.1006/phrs.2000.0758
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Endothelin (ET) is a peptide composed of 21 amino acids, derived from a larger precursor, the big-endothelin, by action of the endothelin-converting enzyme (ECE) family; three isoforms of endothelin, named ET-1, ET-2 and ET-3, have been identified. Endothelin-1 is generated mainly by vascular endothelial cells and exerts various important biological actions, mediated by two receptor subtypes, ET-A and ET-B, belonging to the G protein-coupled family that have been identified in various human tissues such as the cardiac tissue. Endothelin-1 is a potent vasoconstrictive agent, has inotropic and mitogenic actions, modulates salt and water homeostasis and plays an important role in the maintenance of vascular tone and blood pressure in healthy subjects. Endothelin-1, as well as ET-A and ECE-1, also has an important role in cardiovascular development, as observed by the variety of abnormalities related to neural crest-derived tissues in mouse embryos deficient of a member of the ET-1/ECE-1/ET-A pathway. Various evidence indicates that endogenous endothelin-1 may contribute to the pathophysiology of conditions associated with sustained vasoconstriction, such as heart failure. In heart failure, elevated circulating levels of both endothelin-1 and big-endothelin-1 are observed; in failing hearts an activation of the endothelin system is found: tissue level of ET-1 is increased with respect to non-failing hearts as well as receptor density, due mainly to an upregulation of the ET-A subtype, the prevalent receptor subclass in cardiac tissue. Finally, studies in both humans and animal models of cardiovascular disease show that inhibition of the endothelin function (anti-endothelin strategy) is associated with an improvement of haemodynamic conditions; these observations indicate that endothelin receptor antagonists or endothelin-converting enzyme inhibitors may constitute a novel and potentially important class of agents for the treatment of this disease. (C) 2001 Academic Press.
引用
收藏
页码:111 / 126
页数:16
相关论文
共 177 条
[11]   Ontogeny of endothelins-1 and -3, their receptors, and endothelin converting enzyme-1 in the early human embryo [J].
Brand, M ;
Le Moullec, JM ;
Corvol, P ;
Gasc, JM .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (03) :549-559
[12]   Role of ET(B) receptors in local clearance of endothelin-1 in rat heart: Studies with the antagonists PD 155080 and BQ-788 [J].
Brunner, F ;
Doherty, AM .
FEBS LETTERS, 1996, 396 (2-3) :238-242
[13]   PLASMA ENDOTHELIN AND PULMONARY PRESSURES IN PATIENTS WITH CONGESTIVE-HEART-FAILURE [J].
CACOUB, P ;
DORENT, R ;
NATAF, P ;
CARAYON, A ;
MAISTRE, G ;
PIETTE, JC ;
GODEAU, P ;
CABROL, C ;
GANDJBAKHCH, I .
AMERICAN HEART JOURNAL, 1993, 126 (06) :1484-1488
[14]   CARDIORENAL ACTIONS OF ENDOTHELIN .1. EFFECTS OF CONVERTING ENZYME-INHIBITION [J].
CAO, LQ ;
BANKS, RO .
LIFE SCIENCES, 1990, 46 (08) :577-583
[15]   IMMUNOREACTIVE ENDOTHELIN IN HUMAN-PLASMA - MARKED ELEVATIONS IN PATIENTS IN CARDIOGENIC-SHOCK [J].
CERNACEK, P ;
STEWART, DJ .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 161 (02) :562-567
[16]   Role of the stress-activated protein kinases in endothelin-induced cardiomyocyte hypertrophy [J].
Choukroun, G ;
Hajjar, R ;
Kyriakis, JM ;
Bonventre, JV ;
Rosenzweig, A ;
Force, T .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (07) :1311-1320
[17]   Acute effects of an endothelin-1 receptor antagonist bosentan at different stages of heart failure in conscious dogs [J].
Choussat, R ;
Hittinger, L ;
Barbe, F ;
Maistre, G ;
Carayon, A ;
Crozatier, B ;
Su, JB .
CARDIOVASCULAR RESEARCH, 1998, 39 (03) :580-588
[18]  
CLERICO A, 1994, INT J TISSUE REACT, V16, P79
[19]  
Clouthier DE, 1998, DEVELOPMENT, V125, P813
[20]   CONTROL OF THE DUCTUS-ARTERIOSUS - A NEW FUNCTION FOR CYTOCHROME-P450, ENDOTHELIN AND NITRIC-OXIDE [J].
COCEANI, F .
BIOCHEMICAL PHARMACOLOGY, 1994, 48 (07) :1315-1318